Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06225427 |
| Title | Gilteritinib for the Treatment of ALK NSCLC |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | University of Michigan Rogel Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cedars-Sinai Medical Center | NOT_YET_RECRUITING | Los Angeles | California | 90048 | United States | Details |
| Georgetown University | NOT_YET_RECRUITING | Washington D.C. | District of Columbia | 20007 | United States | Details |
| University of Michigan Comprehensive Cancer Center | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |